Role of Iron Therapy in Heart Failure: A Consensus Statement from India
Loading...
Date
2023-03
Journal Title
Journal ISSN
Volume Title
Publisher
Association of Physicians of India
Abstract
Iron deficiency (ID) with or without anemia is frequently observed in patients with heart failure (HF). Uncorrected ID is associated with higher hospitalization and mortality in patients with acute HF (AHF) and chronic HF (CHF). Hence, in addition to chronic renal insufficiency, anemia, and diabetes, ID appears as a novel comorbidity and a treatment target of CHF. Intravenous (IV) ferric carboxymaltose (FCM) reduces the hospitalization risk due to HF worsening and improves functional capacity and quality of life (QOL) in HF patients. The current consensus document provides criteria, an expert opinion on the diagnosis of ID in HF, patient profiles for IV FCM, and correct administration and monitoring of such patients.
Description
Keywords
Citation
Chopra H K, Wander G S, Nair Tiny, Ponde C K, Nanda Navin C, Narula Jagat, Ray Saumitra, Venugopal K, Iyengar S S, Kasliwal R R, Chandra Praveen, Prakash Sunil, Bansal Sandeep, Rana D S, Kerkar Prafulla, Dasbiswas Arup, Sawhney JPS, Shanmungasundram S, Kumar Viveka, Vijayalakshmi I B, Pancholia A K, Sharma Vinod, Kapoor Aditya, Swami Onkar C, Isser H S, Rastogi Vishal, Arora Y K, Omar Ashok K, Sathe Sunil, Rajput Rajeeve, Prabhakar D, Paul G J, Priya Jagia, Poonam Malhotra, G Suryaprakash, Vinod Mittal, Manish Jagia, A Jabir, S S Mishra, S N Routray, Ajay K Sinha, Mohan Bhargava, Kiran Mahmood, Bhatia Mona, Kalra Pramila, Katyal V K, Tandon Rohit, Grover Rahul, Chhabra Abhinav, Shastry N R. Role of Iron Therapy in Heart Failure: A Consensus Statement from India. Journal of the Association of Physicians of India. 2023 Mar; 71(3): 80-87